Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
Passage Bio Announces Pricing of Public Offering
-
Passage Bio (PASG) Announces Launch of 7M Share Proposed Public Offering
-
Passage Bio Announces Launch of Proposed Public Offering
-
Passage Bio Announces Launch of Proposed Public Offering
-
Krystal Biotech (KRYS) Selected as a 'Top Pick' for 2021 by Chardan Capital, Sees 3-4 Major Catalysts
-
Mountain Crest Acquisition Corp. II Announces Closing of Fully-Exercised Over-Allotment Option in Connection with Its Initial Public Offering
-
Mountain Crest Acquisition Corp. II Announces Closing of Fully-Exercised Over-Allotment Option in Connection with Its Initial Public Offering
-
Mountain Crest Acquisition Corp. II Announces Closing of $50 Million Initial Public Offering
-
Mountain Crest Acquisition Corp. II Announces Closing of $50 Million Initial Public Offering
-
Meten EdtechX Announces Completion of its Offer to Exercise Warrants at a Reduced Price
-
Buy Solid Biosciences (SLDB) on Weakness - Chardan Capital
-
UPDATE: Chardan Capital Markets Starts Cabaletta Bio Inc. (CABA) at Buy, $21 PT
-
Mountain Crest Acquisition Corp. II (MCAD) Prices 5M Unit IPO at $10/Unit
-
Mountain Crest Acquisition Corp. II Announces Pricing of $50 Million Initial Public Offering
-
Mountain Crest Acquisition Corp. II Announces Pricing of $50 Million Initial Public Offering
-
Sensorion Announces Initiation of Coverage by Investment Banks Jefferies and Kempen With a “Buy” Recommendation
-
Chardan Capital Markets Starts Vincera Pharma (VINC) at Buy, $33 PT
-
Form 4 Ventoux CCM Acquisition For: Jan 05 Filed by: Chardan International Investments, LLC
-
Ventoux CCM Acquisition Corp. Announces Closing of Over-Allotment Option in Connection with its Initial Public Offering
-
Provention Bio Inc. (PRVB) PT Raised to $40 at Chardan Capital Markets
-
Clene Nanomedicine Closes Merger with Tottenham Acquisition I Limited and Provides Corporate Update
-
Form 4 Ventoux CCM Acquisition For: Dec 30 Filed by: Chardan International Investments, LLC
-
Viveon Health Acquisition Corp. Announces Exercise and Closing of Over-Allotment Option in Public Offering
-
Viveon Health Acquisition Corp. Announces Exercise and Closing of Over-Allotment Option in Public Offering
-
Ventoux CCM Acquisition Corp. Announces Closing of $150 Million Initial Public Offering
-
Viveon Health Acquisition Corp. Announces Closing of $175 Million Initial Public Offering
-
Viveon Health Acquisition Corp. Announces Closing of $175 Million Initial Public Offering
-
Ventoux CCM Acquisition Corp. (VTAQ) Prices 15M Unit IPO at $10/Unit
-
Ventoux CCM Acquisition Corp. Announces Pricing of $150 Million Initial Public Offering
-
Form 3 Ventoux CCM Acquisition For: Dec 23 Filed by: Chardan International Investments, LLC
-
Viveon Health Acquisition Corp. (VHAQ) Prices 17.5M Unit IPO at $10/Unit
-
Viveon Health Acquisition Corp. Announces Pricing of $175 Million Initial Public Offering
-
Viveon Health Acquisition Corp. Announces Pricing of $175 Million Initial Public Offering
-
MeiraGTx Holdings plc (MGTX) PT Raised to 'Street High' $55 at Chardan Capital Markets
-
Globis Acquisition Corp. Announces Closing of $115 Million Initial Public Offering, which Includes Full Exercise of the Underwriters' Over-Allotment Option
-
Globis Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering
-
Globis Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering
-
CRISPR Therapeutics (CRSP) PT Raised to $166 at Chardan Capital Markets
-
Meten EdtechX Announces Temporary Offer Allowing Warrants to be Exercised at a Reduced Price
-
UPDATE: Chardan Capital Markets Downgrades Mesoblast Limited (MESO) to Sell
-
3 Penny Stocks To Buy According To Analysts; 146%-579% Price Targets
-
MeiraGTx Holdings plc (MGTX) Prices 5M Share Offering at $12.85/Sh
-
MeiraGTx (MGTX) Announces Pricing of Public Offering of 5M Ordinary Shares at $12.85/sh
-
MeiraGTx Announces Pricing of Public Offering of Ordinary Shares
-
MeiraGTx Announces Pricing of Public Offering of Ordinary Shares
-
MeiraGTx Holdings plc (MGTX) Announces Proposed 5M Share Public Offering of Ordinary Shares
-
MeiraGTx Announces Proposed Public Offering of Ordinary Shares
-
MeiraGTx Announces Proposed Public Offering of Ordinary Shares
-
Orisun Acquisition Corp. and Ucommune Group Holdings Limited Announce Closing of Business Combination
-
Chardan Acts as Lead Left Book-Runner in Natural Order Acquisition Corp.'s Oversubscribed $230 Million IPO

